Front Row Advisors’s Pediatrix Medical MD Stock Holding History

Front Row Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-248	Closed	-$8K	–	1082
2018 Q4	$8K	Hold	248	–	–	0.01%	438
2018 Q3	$10	Sell	248 -7	-3%	-$321	0.01%	423
2018 Q2	$11	Sell	255 -2	-0.8%	-$96	0.01%	437
2018 Q1	$14K	Sell	257 -5	-2%	-$274	0.01%	391
2017 Q4	$14K	Buy	+262	New	+$12.4K	0.01%	387

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Front Row Advisors's MD Position: Q1 2019 in Review

Front Row Advisors sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 248 shares — an estimated $8K sold.

Front Row Advisors first reported a position in MD in Q4 2017 and held it in 5 quarters. The position peaked at $14K in Q1 2018. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

Front Row Advisors reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
Front Row Advisors sold 248 Pediatrix Medical shares in Q1 2019, an estimated $8K.
Front Row Advisors first reported a position in Pediatrix Medical in Q4 2017 and held it in 5 quarters.
Front Row Advisors's Pediatrix Medical position peaked at $14K in Q1 2018.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on Front Row Advisors's 13F filing for Q1 2019, filed 16 May 2019.